| Nov 4 |
Regeneron: Buying A Promising Pipeline At A Fair Price (Rating Upgrade)
|
| Nov 2 |
Regeneron price target lowered to $1,126 from $1,137 at Truist
|
| Nov 1 |
What Makes Regeneron Pharmaceuticals (REGN) an Attractive Investment Opportunity?
|
| Nov 1 |
Regeneron Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations
|
| Nov 1 |
Regeneron: Investors In Panic Mode On Increased Eylea Fears
|
| Nov 1 |
Regeneron battles Wall Street uncertainty; Madrigal extends fast launch of MASH drug
|
| Nov 1 |
Regeneron Pharmaceuticals Inc (REGN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth ...
|
| Nov 1 |
Q3 2024 Regeneron Pharmaceuticals Inc Earnings Call
|
| Nov 1 |
Decoding Regeneron Pharmaceuticals Inc (REGN): A Strategic SWOT Insight
|
| Oct 31 |
Regeneron Pharmaceuticals files automatic mixed securities shelf
|
